Assessing the association between GLP-1 receptor agonist use and diabetic retinopathy through the FDA adverse event reporting system
Special populations: Pregnancy and breastfeeding represent absolute contraindications for retatrutide research
No membership fee or insurance required, and the medication is HSA/FSA eligible
Insurance coverage plays a big part in who can afford these newer treatments
Reduced Food Cravings For many patients, tirzepatide treatment leads to a significant reduction in food cravings, allowing them to focus on other aspects of their lives
Additional concerning features include bruising associated with systemic symptoms such as fever, unexplained fatigue, weight loss, night sweats, or enlarged lymph nodes, which could indicate hematological malignancy or other serious conditions